Company Name, Ticker, Suppliers, else..

Iqvia Holdings Inc (IQV)

Other Ticker:

Sector • Healthcare Industry • Medical Laboratories

Industry • Medical Laboratories

Sector • Healthcare

Iqvia Holdings Inc

IQV's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

IQV Growth rates comparisons

Looking into Iqvia Holdings Inc growth rates, revenue grew by 2.83 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1712

Medical Laboratories industry recorded deterioration of revenues by -1.7 %

Iqvia Holdings Inc 's net profit deacreased by -28.62 % in IV. Quarter 2022 year on year, to $227 millions.

• More on IQV's Growth

IQV's Valuation comparisons

Iqvia Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Iqvia Holdings Inc PEG ratio is at 2.23 Iqvia Holdings Inc realized cash outflow of $ -0.79per share in trailing twelve-month period.

Company

34.69

PE TTM

Industry

20.16

PE TTM

Company's Price to Sales ratio is at 2.63.
Medical Laboratories industry's Price to Sales ratio is at 2.17.

• More on IQV's Valuation

Total Debt (Millions $)	12,747
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	182,405
Net Income/Employee (TTM) $	13,810
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	-68.03

IQV's Valuation comparisons

Iqvia Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Iqvia Holdings Inc PEG ratio is at 2.23 Iqvia Holdings Inc realized cash outflow of $ -0.79per share in trailing twelve-month period.

Company

34.69

PE TTM

Industry

20.16

PE TTM

Company's Price to Sales ratio is at 2.63.
Medical Laboratories industry's Price to Sales ratio is at 2.17.

Iqvia Holdings Inc Price to Book Ratio is at 6.58 lower than Indusry Avg. of 360.6. and higher than S&P 500 Avg. of -0.01

• More on IQV's Valuation

• Market Capitalization (Millions $)	37,935
• Shares Outstanding (Millions)	191
• Employees	79,000
• Revenues (TTM) (Millions $)	14,410
• Net Income (TTM) (Millions $)	1,091
• Cash Flow (TTM) (Millions $)	-150
• Capital Exp. (TTM) (Millions $)	-674
• Total Debt (Millions $)	12,747
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	182,405
• Net Income/Employee(TTM) $	13,810
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	-68.03

• Market Capitalization (Millions $)	37,935
• Shares Outstanding (Millions)	191
• Employees	79,000
• Revenues (TTM) (Millions $)	14,410
• Net Income (TTM) (Millions $)	1,091
• Cash Flow (TTM) (Millions $)	-150
• Capital Exp. (TTM) (Millions $)	-674

IQV's Profitability Comparisons
Iqvia Holdings Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2022 to 10.14 % from 13.25 % in III. Quarter. Iqvia Holdings Inc net profit margin of 6.07 % is currently ranking no. 8 in Medical Laboratories industry, ranking no. 152 in Healthcare sector and number 1699 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	1.32
• Total Debt to Equity (MRQ)	2.21
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.58
• Inventory Turnover Ratio (TTM)	-

IQV's Profitability Comparisons

Iqvia Holdings Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in IV. Quarter 2022 to 10.14 % from 13.25 % in III. Quarter.

Iqvia Holdings Inc net profit margin of 6.07 % is currently ranking no. 8 in Medical Laboratories industry, ranking no. 152 in Healthcare sector and number 1699 in S&P 500.

• More on IQV's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar MTAC's Profile Stock Price MTAC's Financials Business Description Fundamentals Charts & Quotes MTAC's News Suppliers MTAC's Competitors Customers & Markets Economic Indicators MTAC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071